Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Therapeutic developments in amyotrophic lateral sclerosis
E. C. Lai
Stanley H. Appel Department of Neurology
Academic Institute
Neurological Institute
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Review article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic developments in amyotrophic lateral sclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Amyotrophic Lateral Sclerosis
100%
Nerve Growth Factors
33%
Disease Progression
24%
Riluzole
23%
Excitatory Amino Acid Antagonists
19%
Gabapentin
19%
Insulin-Like Growth Factor I
15%
Therapeutics
15%
Motor Neurons
15%
Nervous System Diseases
14%
Glutamic Acid
13%
Pharmaceutical Preparations
12%
Antioxidants
11%
Oxidative Stress
11%
Clinical Studies
10%
Muscles
9%
Survival
8%